High Dose Rate Brachytherapy for Oesophageal Cancer
Author Information
Author(s): BG Taal, BMP Aleman, CCE Koning, H Boot
Primary Institution: Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis
Hypothesis
Can high dose rate brachytherapy before external beam irradiation effectively relieve dysphagia in patients with inoperable oesophageal cancer?
Conclusion
Brachytherapy before external beam radiotherapy is a safe and effective method for quickly relieving dysphagia in patients with inoperable oesophageal cancer.
Supporting Evidence
- Complete remission was observed in 21 patients and partial response in 38 patients, leading to an overall response rate of 80%.
- Improvement in dysphagia was noted in 70% of patients by the end of treatment.
- Median survival for patients was 9 months.
Takeaway
Doctors used a special type of radiation treatment to help people with a hard time swallowing because of cancer, and it worked really well for many of them.
Methodology
Patients received 10 Gy HDR brachytherapy followed by 40 Gy external beam radiotherapy over 4 weeks, with evaluations of symptoms and tumor response.
Potential Biases
Potential understaging of disease due to reliance on non-surgical diagnostic methods.
Limitations
The study had a relatively small sample size and focused on short-term outcomes; long-term survival rates remain poor.
Participant Demographics
74 patients, 70% male, median age 67 years, with squamous cell carcinoma and adenocarcinoma.
Want to read the original?
Access the complete publication on the publisher's website